Literature DB >> 7462596

Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection.

J S Oxford, L R Haaheim, A Slepushkin, J Werner, E Kuwert, G C Schild.   

Abstract

The specificity of serum anti-HA antibody from children immunized or infected with A/Victoria/75 (H3N2 or A/Texas/77 (H3N2) virus was examined using the single radial haemolysis test together with adsorption of antibody with three antigenic variants A/Hong Kong/68 (H3N2), A/Port Chalmers/73 (H3N2) and A/Victoria/75 (H3N2). The majority of young children reacted to vaccination or infection by producing strain-specific (SS) antibody to the homologous virus. A small proportion of children's sera contained cross-reacting (CR) antibodies capable of reacting with the haemagglutinins of all antigenic variants of the sub-type including A/HK/1/68. In contrast, most adults reacted immunologically to either vaccination or infection by producing CR antibody, reacting with all variants of the antigenic subtype including the prototype virus A/HK/1/68 (H3N2).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462596      PMCID: PMC2134063          DOI: 10.1017/s0022172400068704

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

Review 1.  Determinants of immunity to influenza infection in man.

Authors:  C W Potter; J S Oxford
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

2.  Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains.

Authors:  W G Laver; J C Downie; R G Webster
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

3.  Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.

Authors:  T W Hoskins; J R Davies; A J Smith; C L Miller; A Allchin
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

4.  Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule.

Authors:  J W Yewdell; R G Webster; W U Gerhard
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

5.  Immunity to influenza as related to antibody levels.

Authors:  J A Morris; J A Kasel; M Saglam; V Knight; F A Loda
Journal:  N Engl J Med       Date:  1966-03-10       Impact factor: 91.245

6.  Antigenicity of licensed whole virion and subvirion influenza vaccines in "high risk" persons.

Authors:  J A Kasel; R B Couch; H R Six; V Knight
Journal:  Proc Soc Exp Biol Med       Date:  1976-04

7.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

8.  Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.

Authors:  C W Potter; R Jennings; K Nicholson; D A Tyrrell; K G Dickinson
Journal:  J Hyg (Lond)       Date:  1977-12

9.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

10.  The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin.

Authors:  W Gerhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  12 in total

1.  Antigenic properties of some equine influenza viruses.

Authors:  R Burrows; M Denyer
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).

Authors:  C W Potter; R Jennings; M J Ali; J M Wood; U Dunleavy; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

3.  Use of monoclonal anti-haemagglutinin antibodies for the "in vitro" selection of a sequential influenza virus antigenic variant.

Authors:  A Natali; C Chezzi
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

4.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

5.  Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.

Authors:  A Natali; P F Panizzi; C Chezzi; J S Oxford
Journal:  J Hyg (Lond)       Date:  1984-04

6.  The HI test modified by ether treatment in the sero-epidemiological surveillance of influenza B.

Authors:  R Pyhälä; M Kleemola; R Visakorpi
Journal:  J Hyg (Lond)       Date:  1985-06

7.  Detection of antibodies to strain-specific and cross-reactive antigenic determinants on the haemagglutinin of influenza viruses A/Texas/1/77 and A/Bangkok/1/79 in human sera. Brief report.

Authors:  G Mancini; I Donatelli; G Arangio Ruiz; C Rozera
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody.

Authors:  A Natali; J S Oxford; G C Schild
Journal:  J Hyg (Lond)       Date:  1981-10

9.  Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis.

Authors:  J S Oxford; R Yetts; G C Schild
Journal:  J Hyg (Lond)       Date:  1982-04

10.  Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).

Authors:  J Mumford; J M Wood; A M Scott; C Folkers; G C Schild
Journal:  J Hyg (Lond)       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.